Project Grant HT94252510033
Award Date
3/1/25
Completion Date
2/29/28
Dollars Obligated
$1.6M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
La Jolla, CA 92093, USA
Similar Awards
The University of California, San Diego (UCSD) has been awarded a $316,000.00 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). This two-year award, effective from February 1, 2024 to January 31, 2026, will support research to investigate "POSTVIRAL DYNAMICS AND DYSFUNCTION OF THE AUTONOMIC NERVOUS SYSTEM VIA ADHERENCE-INDEPENDENT LONGITUDINAL CARDIOPULMONARY MONITORING." The Military Medical...
The University of California, San Diego (UCSD) was awarded a $1,184,999 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support UCSD's project "QUANTITATIVE ADVANCED DIFFUSION MRI FOR RELIABLE DETECTION AND ENHANCED TREATMENT OF HIGH-GRADE PROSTATE CANCER" from July 1, 2023 to June 30, 2027. Through this funding, UCSD will conduct research to advance the detection and treatment of high-grade prostate...
This federal Project Grant award from the Department of the Army Medical Command (CFDA 12.420 - Military Medical Research and Development) provides $361,931 to the University of California, San Diego (UCSD) to investigate microglia dysfunction in MEF2C deficiency autism spectrum disorder, with the goal of discovering new targeted therapies. The award period runs from September 30, 2024 to September 29, 2027. UCSD, a leading academic research institution, will leverage its expertise in...
The Department of the Army Medical Command has awarded a $1,557,266 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program to the University of California, Los Angeles (UCLA) to elucidate the molecular pathways by which proinflammatory microbes induce the development of interstitial cystitis. This 4-year research project, with a start date of March 1, 2025 and an ultimate completion date of February 28, 2029, aims to advance scientific understanding...
The University of California, San Diego was awarded a $553,000 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research to identify NUAK-1 as a novel target for the treatment of appendiceal cancer. The research project commenced on August 15, 2023 and is scheduled for completion on February 14, 2026. The funded activities aim to transform healthcare for Service Members and the American public through...
The University of California, San Diego (UCSD) was awarded a $1,218,012 Project Grant from the Defense Health Agency on September 30, 2023 under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "GERMLINE INFLUENCE ON PROSTATE CANCER METASTASIS AND TREATMENT RESPONSE." The research aims to transform health care for Service Members and the American public by investigating medical solutions for the battlefield through innovative and impactful...
This federal Project Grant award of $2,377,839.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports evidence-based prediction of cardiovascular risk in immune-mediated inflammatory disease. The award, granted to the Regents of the University of California, San Francisco on June 1, 2025, aims to advance biomedical research and transform healthcare for military service members and the broader public. The 4-year research...
The University of Queensland in Australia was awarded a $296,964 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from March 1, 2023 to February 28, 2025 to investigate epithelial tissue mechanics as a potential new factor in relapse for chronic inflammatory bowel disease. Through this funding, researchers aim to gain insights that could transform healthcare for service members and the public by...
The Defense Health Agency awarded a $2,528,000 Project Grant to the University of California, San Diego under the Military Medical Research and Development federal grant program (CFDA 12.420) to support research titled "MULTIPLEXED IN VIVO EPIGENOME ENGINEERING FOR THERAPEUTIC TARGETING OF CHRONIC PAIN." The four-year project beginning June 1, 2022 will investigate medical solutions for chronic pain through innovative epigenome engineering research with the goal of transforming...
The University of California, San Diego (UCSD) was awarded a $790,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support UCSD research to mitigate traumatic brain injuries and neurological implications via the immunometabolite itaconate from June 1, 2023 through May 31, 2026. The Military Medical Research and Development program aims to transform military and public health care through...